Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 21, 2024

BUY
$6.66 - $10.64 $2,997 - $4,788
450 Added 116.28%
837 $6,000
Q3 2023

Oct 30, 2023

BUY
$6.66 - $10.64 $2,997 - $4,788
450 Added 116.28%
837 $7,000
Q2 2023

May 21, 2024

SELL
$8.86 - $14.0 $70 - $112
-8 Reduced 2.03%
387 $3,000
Q2 2023

Jul 27, 2023

SELL
$8.86 - $14.0 $70 - $112
-8 Reduced 2.03%
387 $4,000
Q1 2023

May 21, 2024

BUY
$13.74 - $25.76 $1,360 - $2,550
99 Added 33.45%
395 $5,000
Q1 2023

Apr 27, 2023

BUY
$13.74 - $25.76 $1,360 - $2,550
99 Added 33.45%
395 $5,000
Q4 2022

May 21, 2024

BUY
$15.45 - $26.02 $4,573 - $7,701
296 New
296 $5,000
Q4 2022

Jan 31, 2023

BUY
$15.45 - $26.02 $370 - $624
24 Added 8.82%
296 $5,000
Q3 2022

Oct 21, 2022

BUY
$15.42 - $27.01 $4,194 - $7,346
272 New
272 $6,000

Others Institutions Holding IGMS

About IGM Biosciences, Inc.


  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.